RICCO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 294
AS - Asia 68
EU - Europa 60
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 426
Nazione #
US - Stati Uniti d'America 287
CN - Cina 37
SG - Singapore 19
IT - Italia 18
SE - Svezia 16
BG - Bulgaria 14
VN - Vietnam 10
CA - Canada 7
DE - Germania 6
FI - Finlandia 3
CI - Costa d'Avorio 2
CL - Cile 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IN - India 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 426
Città #
Woodbridge 43
Fairfield 39
Cambridge 29
Ann Arbor 20
Ashburn 19
Houston 19
Seattle 18
Wilmington 15
Sofia 14
Chandler 12
New York 12
Beijing 11
Singapore 8
Xian 8
Princeton 7
Des Moines 6
Lawrence 6
Ogden 5
Ottawa 5
Florence 4
Medford 4
Frankfurt am Main 3
Guangzhou 3
Rome 3
Abidjan 2
Milan 2
Nanjing 2
Pisa 2
Auckland 1
Changsha 1
Council Bluffs 1
Dallas 1
Dearborn 1
Dong Ket 1
Hangzhou 1
Hebei 1
Kilburn 1
Kunming 1
Lappeenranta 1
Los Angeles 1
Monsummano Terme 1
Montreal 1
Nanchang 1
Naples 1
Norwalk 1
Nuremberg 1
Prague 1
Pune 1
Riyadh 1
Saluggia 1
San Diego 1
San Francisco 1
Shenyang 1
Toronto 1
Trani 1
Wuhan 1
Totale 349
Nome #
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases 98
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease 90
Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection. 83
null 58
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma. 35
Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection? 28
A cost-effectiveness model to personalize antiviral therapy in naive patients with genotype 1 chronic hepatitis C. 17
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy 14
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection 6
Highly dynamic changes of regional HBV epidemiology over two decades. 5
Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease 5
Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index 3
EASLClinical Practice Guidelines on hepatitis delta virus. 3
Totale 445
Categoria #
all - tutte 1.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 16 8 1 5 8 14 10 9 8 9 5 2
2020/202175 2 2 1 1 3 14 7 2 7 1 25 10
2021/202251 0 0 2 0 11 9 1 1 5 0 3 19
2022/202357 7 2 3 5 8 10 0 2 11 0 8 1
2023/202471 6 0 6 2 2 18 8 1 1 1 14 12
Totale 445